Absence of CX3CR1 impairs the internalization of Tau by microglia

Table 1 Table shows epidemiological information on human brain tissue samples from the hippocampus

	CODE	AGE	GENDER	POST-MORTEM INTERVAL	BRAAK-TAU	DIAGNOSIS
CONTROL	1	65	MALE	3	0	Methastasis
	2	52	FEMALE	6	0	Mental retardation
	3	75	FEMALE	1	0	Neuropathy
	4	71	MALE	5,5	0	FTD
	5	78	MALE	4	0	Dyslipidemia
	6	80	MALE	3	0	Neuropathy
	7	43	MALE	5	0	Leukaemia
	8	56	FEMALE	5	0	ALS
	9	68	MALE	4	0	MSA
	10	41	MALE	6	0	ALS
BRAAK-TAU I and II	11		FEMALE	6	I	ALS
	12	67	FEMALE	6	I	ALS
	13	82	MALE	5	I	PD
	14	73	MALE	9	I	AD
	15	76	MALE	3	II	PD
	16	73	MALE	6,5	II	Vascular dementia
BRAAK-TAU III and IV	17	80	FEMALE	5	III	ALS
	18	85	MALE	8,5	III	Dementia
	19	70	FEMALE	9	III	ALS
	20	82	FEMALE	3,5	IV	FTD
	21	79	MALE	4,5	IV	AD
	22	62	MALE	5	IV	PD
BRAAK-TAU V and VI	23	93	FEMALE	5,5	V	AD
	24	92	MALE	4	V	AD
	25	73	MALE	5	V	AD
	26	80	MALE	5	V	AD
	27	81	MALE	2,5	V	AD
	28		FEMALE	4	V	AD
	29	85	MALE	2,5	V	AD
	30	89	FEMALE	6	V	AD
	31	93	MALE	8	V	AD
	32	86	FEMALE	?	V	AD
	33	82	FEMALE	?	V	AD
	34	78	FEMALE	6,5	V	AD
	35	84	MALE	4	VI	AD
	36	91	FEMALE	3	VI	AD
	37	92	FEMALE	?	VI	AD
	38	83	FEMALE	3,5	VI	AD
	39	87	MALE	10	VI	AD
	40	90	FEMALE	10	VI	AD
	41	89	FEMALE	4,5	VI	AD
	42	60	MALE	4,5	VI	AD
	43	55	MALE	5	VI	AD
	44	92	MALE	6	VI	AD
	45	77	MALE	9	VI	AD

Control, Braak-Tau I and II, Braak-Tau III and IV, and Braak-Tau V and VI groups are shown. Information regarding code, age, gender, postmortem interval, Braak-Tau stage and diagnosis of each sample is indicated

ISSN: 1750-1326